Epidemiological and clinical aspects of migraine in users of combined oral contraceptives

Contraception

Volumn 81, Issue 3, 2010, Pages 202-208

  Machado, Rogério Bonassi ^a   Pereira, Alice Pinheiro ^a   Coelho, Geórgia Perez ^a   Neri, Larissa ^a   Martins, Larissa ^a   Luminoso, Daniele ^a  

^a Medicine School of Jundiaí   (Brazil)

Author keywords

Headache; Hormone; Menstrual migraine; Menstruation; Migraine; Oral contraceptives

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL MIGRAINE; MENSTRUATION; MIGRAINE; MIGRAINE AURA; MORBIDITY; ORAL CONTRACEPTION; PERIODICITY; PREVALENCE;

ADULT; CONTRACEPTIVES, ORAL, COMBINED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIGRAINE DISORDERS; ODDS RATIO; PATIENT SELECTION; PREVALENCE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; WOMEN'S HEALTH;

EID: 76049108936     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.09.006     Document Type: Article

References (27)

1. Rasmussen B.K. Epidemiology of headache. Cephalalgia 15 (1995) 45-68
2. Lipton R.B., Diamond S., Reed M., Diamond M.L., and Stewart W.F. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41 (2001) 638-645
3. MacGregor A. Migraine associated with menstruation. Funct Neurol 15 Suppl 3 (2000) 143-153
4. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders: 2nd edition. Cephalalgia 24 suppl 1 (2004) 9-160
5. Curtis K.M., Mohllajee A.P., and Peterson H.B. Use of combined oral contraceptives among women with migraine and nonmigrainous headaches: a systematic review. Contraception 73 (2006) 189-194
6. Loder E.W., Buse D.C., and Golub J.R. Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol 193 3 Pt 1 (2005) 636-649
7. Sulak P. Ovulation suppression of premenstrual symptoms using oral contraceptives. Am J Manag Care 11 16 Suppl (2005) S492-S497
8. Calhoun A.H. Migraine and menopause. Headache 44 (2004) 106
9. Edelson R.N. Menstrual migraine and other hormonal aspects of migraine. Headache 25 (1985) 376-379
10. Lipton R.B., Stewart W.F., Diamond S., Diamond M.L., and Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41 (2001) 646-657
11. MacGregor E.A., and Hackshaw A. Prevalence of migraine on each day of the natural menstrual cycle. Neurology 63 (2004) 351-353
12. Neri I., Granella F., Nappi R., Manzoni G.C., Facchinetti F., and Genazzani A.R. Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 17 (1993) 31-37
13. Stein G.S. Headaches in the first post partum week and their relationship to migraine. Headache 21 (1981) 201-205
14. Aegidius K., Zwart J.A., Hagen K., Schei B., and Stovner L.J. Oral contraceptives and increased headache prevalence: the Head-HUNT Study. Neurology 66 (2006) 349-353
15. Fotherby K. Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel. Contraception 51 (1995) 3-12
16. Fotherby K. Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms estrogen. Contraception 46 (1992) 477-488
17. Kelman L. The aura: a tertiary care study of 952 migraine patients. Cephalalgia 24 (2004) 728-734
18. Ernst U., Baumgartner L., Bauer U., and Janssen G. Improvement of quality of life in women using a low-dose desogestrel containing contraceptive: results of an observational clinical evaluation. Eur J Contracept Reprod Health Care 7 (2002) 238-243
19. Brill K., Schnitker J., and Albring M. Long-term experience with a low-dose oral contraceptive. Gynecol Endocrinol 4 (1990) 277-286
20. Sulak P.J., Scow R.D., Preece C., Riggs M., and Kuehl T.J. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 95 (2000) 261-266
21. Sulak P., Willis S., Kuehl T., Coffee A., and Clark J. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 47 (2007) 27-37
22. LaGuardia K.D., Fisher A.C., Bainbridge J.D., LoCoco J.M., and Friedman A.J. Suppression of estrogen-withdrawal headache with extended transdermal contraception. Fertil Steril 83 (2005) 1875-1877
23. Cupini L.M., Matteis M., Troisi E., Calabresi P., Bernardi G., and Silvestrini M. Sex-hormone-related events in migrainous females. A clinical comparative study between migraine with aura and migraine without aura. Cephalalgia 15 (1995) 140-144
24. Granella F., Sances G., Pucci E., Nappi R.E., Ghiotto N., and Napp G. Migraine with aura and reproductive life events: a case-control study. Cephalalgia 20 (2000) 701-707
25. MacGregor E.A. Migraine, the menopause and hormone replacement therapy: a clinical review. J Fam Plann Reprod Health Care 33 (2007) 245-249
26. Genazzani A.R., Pluchino N., Begliuomini S., et al. Drospirenone increases central and peripheral beta-endorphin in ovariectomized female rats. Menopause 14 (2007) 63-73
27. Vujović S., Zidverc J., Stojanović M., et al. Drospirenone in the treatment of severe premenstrual cerebral edema in a woman with antiphospholipid syndrome, lateral sinus thrombosis, situs inversus and epileptic seizures. Gynecol Endocrinol 21 (2005) 243-247